Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation (Q80512153)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Vlad G

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ho EK

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Vasilescu ER

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Fan J

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Liu Z

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Cai JW

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jin Z

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Burke E

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Deng M

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Cadeiras M

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Cortesini R

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Itescu S

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Marboe C

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Mancini D

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Suciu-Foca N

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

2 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

published in

Transplant Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

13-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

Induction immunosuppression

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Use of IL-2 receptor antagonists to reduce delayed graft function following renal transplantation: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Daclizumab induction and maintenance steroid-free immunosuppression with mycophenolate mofetil and tacrolimus to prevent acute rejection of hepatic allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Natural versus adaptive regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

License to heal: bidirectional interaction of antigen-specific regulatory T cells and tolerogenic APC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Type 1 T Regulatory Cells and Their Relationship with CD4+ CD25+ T Regulatory Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Acute antibody-mediated rejection of cardiac transplants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Anti-HLA antibodies in heart transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Alloantibodies and the outcome of cadaver kidney allografts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Regulatory T cells in the induction and maintenance of peripheral transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Proinflammatory functions of vascular endothelial growth factor in alloimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Toll-like receptor stimulation as a third signal required for activation of human naive B cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Recombinant Ig-like transcript 3-Fc modulates T cell responses via induction of Th anergy and differentiation of CD8+ T suppressor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Regulatory T cells in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

TCR transgenic CD8+ T cells activated in the presence of TGFbeta express FoxP3 and mediate linked suppression of primary immune responses and cardiac allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

FOXP3+ regulatory T cells: Current controversies and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Regulatory T cells in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Transient regulatory T-cells: a state attained by all activated human T-cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

7 January 2021

FOXP3: of mice and men.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.03.001

10.1016/J.TRIM.2007.03.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17584597%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference